Loading...
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
In 2020, despite challenges related to the COVID-19 pandemic, the US FDA approved 30 new drugs and biologic agents, 45 supplemental drug and biologic applications and 1 biosimilar application in oncology.
Na minha lista:
| Udgivet i: | Nat Rev Clin Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Publishing Group UK
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7844812/ https://ncbi.nlm.nih.gov/pubmed/33514911 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41571-021-00477-1 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|